Prilosec OTC Bioequivalence To Rx Version “Has No Impact” – P&G

The lack of bioequivalence between Prilosec OTC (omeprazole) and Rx Prilosec is irrelevant to the product's OTC status because FDA approved the OTC version's toxicological profile as part of its review, Procter & Gamble maintains